NASDAQ:CLYM | Free Cash Flow | Climb Bio, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2020-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$14.38M
2025-12-31-$15.64M$0.00-$15.64M
2025-03-31-$15.43M
2024-12-31-$5.52M$0.00-$5.52M
2024-03-31-$1.82M
2023-12-31-$947,000.00
2023-03-31-$15.18M
2022-12-31-$8.45M
2022-03-31-$10.78M
2021-12-31-$7.88M
2021-03-31-$6.74M
2020-12-31-$5.62M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$54.36M$186,000.00-$54.54M
2024-12-31-$15.56M$0.00-$15.56M
2023-12-31-$20.6M
2022-12-31-$37.37M
2021-12-31-$36.07M
2020-12-31-$14.1M